Drug profile · INN
diltiazem malate
TECZEM
diltiazem malate (TECZEM) is a voltage-gated l-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Drug details — diltiazem malate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
diltiazem malate (TECZEM) is a voltage-gated l-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated L-type calcium channel blocker
Primary target: Voltage-gated L-type calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is diltiazem malate?
diltiazem malate (TECZEM) is a voltage-gated l-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for diltiazem malate?
TECZEM is a marketed brand name for diltiazem malate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diltiazem malate?
diltiazem malate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.